ChartRow logo
EXEL
$72.77+0.64%
as of close, Nov 4, 2026
☾ AH $72.77 +0.64%
Share this page

EXEL financial statements

The full income statement, balance sheet, and cash-flow statement for Exelixis Inc. (EXEL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +18.6%10Y CAGR +51.2%YoY +10.2%
$2.5B TTM$658.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +18.6%10Y CAGR +52.3%YoY +9.2%
$2.4B TTM$632.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +51.3%10Y n/mYoY +13.5%
$1B TTM$268.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +47.6%10Y n/mYoY +12.7%
$885.1M TTM$218.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +51.4%10Y n/mYoY +23.2%
$3.34 TTM$0.85 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +33.4%10Y n/mYoY −3.6%
$1.2B TTM$280M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR −22.6%10Y CAGR +34.1%YoY +67.9%
$12M TTM$2.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +37.4%10Y n/mYoY −3.9%
$1.2B TTM$277.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −11.4%10Y +34.7%YoY −8.2%
264.8M TTM255.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares outstanding (point-in-time)

2024-09 285.6M2025-01 279.9M2025-04 272.7M2025-07 269.2M2025-10 268.1M2026-01 259.7M2026-04 251.4M2026-07 247.8M2026-10 244.0M-14.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofJan 2 ’26as ofJan 3 ’25as ofDec 29 ’23as ofDec 30 ’22as ofDec 31 ’21
Revenue2.32B+7.0%2.17B+18.5%1.83B+13.6%1.61B+12.3%1.43B+45.3%
2.24B+6.9%2.09B+19.0%1.76B+13.2%1.55B+12.4%1.38B+45.3%
Cost of revenue83.7M+9.8%76.2M+5.1%72.5M+25.3%57.9M+9.5%52.9M+45.8%
Research & development825M-9.4%910M-12.8%1.04B+17.1%892M+28.6%694M+26.6%
Selling, general & administrative519M+5.4%492M-9.3%543M+18.0%460M+14.5%402M+36.9%
Restructuring20.5M-39.1%33.7M0.000.00—
Operating income872M+44.3%605M+253.8%171M-15.2%201M-29.7%287M+160.5%
Other non-operating income-198K-48.9%-133K-243.0%93.0K+147.2%-197K-7.1%-184K-120.2%
Income tax159M-1.1%160M+222.3%49.8M-4.4%52.1M-17.5%63.1M+231.1%
783M+50.1%521M+150.9%208M+14.0%182M-21.1%231M+106.7%
Net income to common783M+50.1%521M+150.9%208M+14.0%182M-21.1%231M+106.7%
$2.78+58.0%$1.76+170.8%$0.65+16.1%$0.56-22.2%$0.72+105.7%
EPS (basic)$2.88+60.0%$1.80+176.9%$0.65+14.0%$0.57-21.9%$0.73+102.8%
Weighted-avg shares (basic)272M-6.4%290M-8.8%318M-1.0%322M+2.1%315M+2.1%
Weighted-avg shares (diluted)282M-4.8%296M-7.9%321M-1.0%325M+0.7%322M+1.4%
Balance Sheetas ofJan 2 ’26as ofJan 3 ’25as ofDec 29 ’23as ofDec 30 ’22as ofDec 31 ’21
1.44B-1.7%1.47B+11.4%1.32B-18.6%1.62B-11.8%1.83B+26.9%
Cash & equivalents482M+122.0%217M-17.3%263M-47.5%501M-22.6%647M+102.7%
Short-term investments577M-35.5%894M+22.1%732M-9.3%807M-1.5%820M-7.6%
Accounts receivable287M+8.1%265M+11.8%237M+10.5%215M-24.0%283M+75.7%
Inventory21.7M-3.1%22.4M+29.2%17.3M-48.0%33.3M+21.1%27.5M+31.1%
Prepaid expenses75.6M+10.4%68.5M+0.8%67.9M+9.2%62.2M+8.1%57.5M+0.9%
2.84B-3.5%2.95B+0.2%2.94B-4.2%3.07B+17.4%2.62B+22.4%
Property, plant & equipment99.0M-17.1%119M-7.3%129M+16.4%111M+6.3%104M+54.4%
Operating lease right-of-use159M-7.8%173M-26.0%233M-0.7%235M+420.4%45.1M+4.9%
Goodwill63.7M+0.0%63.7M+0.0%63.7M+0.0%63.7M+0.0%63.7M+0.0%
Long-term investments604M-5.3%637M-12.5%729M-3.7%757M+103.9%371M+12.2%
Deferred tax assets293M-30.3%420M+16.3%361M+56.3%231M+107.0%112M-28.7%
Other non-current assets
————131M+78.5%
406M+0.5%404M+2.4%394M+21.6%324M-3.9%338M+65.0%
Accounts payable29.6M-22.4%38.2M+13.1%33.8M+3.4%32.7M+34.7%24.3M+2.6%
Deferred revenue1.11M-59.3%2.74M-49.3%5.41M-27.8%7.49M-4.2%7.81M+336.5%
Current lease liability27.9M+11.5%25.0M-2.7%25.7M+45.6%17.7M+243.8%5.14M+69.8%
Other current liabilities125M+32.0%95.0M-12.4%108M+37.4%78.9M+47.9%53.4M+20.1%
683M-2.9%703M+3.7%678M+16.4%583M+43.7%406M+57.1%
Deferred revenue (non-current)6.11M+80.2%3.39M-38.6%5.52M-16.1%6.58M-24.7%8.74M+132.7%
Non-current lease liability173M-9.3%191M+0.5%190M-0.1%190M+270.9%51.3M+4.5%
Operating lease liability (total)201M-6.9%216M+0.1%216M+3.8%208M+268.4%56.4M+8.2%
Other non-current liabilities104M-4.1%109M+15.6%94.2M+37.5%68.5M+754.2%8.02M+1012.8%
2.16B-3.7%2.24B-0.9%2.26B-9.0%2.49B+12.6%2.21B+17.6%
Preferred stock0.000.000.000.000.00
Common stock262K-7.1%282K-6.9%303K-6.5%324K+1.6%319K+2.2%
Additional paid-in capital2.23B-4.7%2.34B-4.0%2.44B-3.8%2.54B+4.5%2.43B+4.6%
Retained earnings-76.8M+22.1%-98.6M+43.1%-173M-406.5%-34.2M+84.2%-217M+51.6%
Accumulated other comprehensive income3.48M+358.1%-1.35M+64.1%-3.75M+74.2%-14.5M-1815.7%-758K-116.9%
Total equity incl. non-controlling2.16B-3.7%2.24B-0.9%2.26B-9.0%2.49B+12.6%2.21B+17.6%
Total liabilities & equity2.84B-3.5%2.95B+0.2%2.94B-4.2%3.07B+17.4%2.62B+22.4%
Common shares issued262M-6.8%282M-7.0%303M-6.5%324M+1.6%319M+2.3%
Common shares outstanding262M-6.8%282M-7.0%303M-6.5%324M+1.6%319M+2.3%
Shares outstanding (cover)260M-7.2%280M-7.7%303M-6.4%324M+1.5%319M+2.4%
Cash Flowas ofJan 2 ’26as ofJan 3 ’25as ofDec 29 ’23as ofDec 30 ’22as ofDec 31 ’21
884M+26.3%700M+110.0%333M-8.1%363M-9.5%401M+91.8%
Depreciation & amortization29.1M+0.9%28.8M+12.0%25.7M+23.2%20.9M+53.2%13.6M+49.1%
Share-based compensation113M+20.4%93.8M-11.8%106M-1.1%108M-10.2%120M+14.0%
Deferred income taxes126M+312.3%-59.5M+55.4%-133M-120.7%-60.4M-229.7%46.5M+204.8%
Change in receivables21.4M-23.4%27.9M+23.5%22.6M+133.8%-66.8M-154.6%122M+188.0%
Change in inventory-12.2M-124.2%-5.45M-142.0%13.0M+11.1%11.7M-11.6%13.2M-39.7%
Change in payables-50.2M-129.2%-21.9M-143.7%50.1M+114.5%23.4M-57.6%55.1M+9.1%
350M+400.1%-117M-333.3%-27.0M+94.9%-524M-1122.9%-42.9M+67.3%
Capital expenditure8.43M-70.4%28.4M-29.7%40.5M+46.1%27.7M-48.9%54.2M+78.7%
Free cash flow876M+30.4%672M+129.3%293M-12.6%335M-3.4%347M+94.0%
Acquisitions0.000.000.000.000.00
Purchases of investments——902M-37.8%1.45B+6.9%1.36B+26.8%
Sales/maturities of investments——1.04B-2.5%1.06B-22.8%1.38B+42.2%
-970M-54.2%-629M-15.2%-546M-93282.9%586K+104.0%-14.8M+41.1%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased948M+45.3%652M+18.5%550M0.000.00
Dividends paid0.000.000.000.000.00
Other financing activities
————0.00
Net change in cash265M+681.1%-45.6M+81.0%-240M-48.7%-161M-147.0%343M+551.9%
Income taxes paid155M-8.9%170M-8.2%186M+45.2%128M+886.7%13.0M+214.9%
Valuation Ratiosas ofJan 2 ’26as ofJan 3 ’25as ofDec 29 ’23as ofDec 30 ’22as ofDec 31 ’21
Market cap11.4B+19.5%9.57B+31.8%7.26B+39.8%5.20B-10.8%5.83B-6.4%
P/E14.6×-20.4%18.4×-47.5%35.0×+22.6%28.5×+13.0%25.2×-38.4%
P/S4.9×+11.7%4.4×+11.2%4.0×+23.1%3.2×-20.6%4.1×-37.5%
P/B5.3×+24.1%4.3×+32.9%3.2×+53.7%2.1×-20.8%2.6×-21.6%
P/FCF13.1×-8.4%14.3×-42.5%24.8×+59.9%15.5×-7.7%16.8×-16.2%
Earnings yield6.8%+25.6%5.4%+90.4%2.9%-18.5%3.5%-11.5%4.0%+62.3%
FCF yield7.7%+9.1%7.0%+74.0%4.0%-37.4%6.4%+8.4%5.9%+19.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: EXEL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EXEL filings on SEC EDGAR → Not investment advice.